Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: john couch who wrote (2616)	7/17/1998 8:24:00 PM
From: Brian Moloney	Respond to of 3725

John, I know that there are a lot of things that you cannot talk about. My point is that many of us have been disappointed that there has not been made a much stronger attempt to market this amazing and potentially life-saving technology. Sort of like a sports fans whose team is not playing well, we make excuses. First Sieman's is screwing us, then the doctors are self-serving or poorly informed (I agree with this and remember that I am a physician), then the insurance companies are screwing us. It's always wait until next quarter. While I can understand the good-faith reluctance of some of my colleagues to fall in love with this technology in its simple form, the applications with contrast are stunning. It would seem that a concerted effort to market these "advanced" applications to all of the different customers would pay off. Maybe this is all in the plans with GE, but it is frustrating for us to wait not knowing how hard management is trying.